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Derivation of patient-specific human pluripotent
stem cells via somatic cell nuclear transfer (SCNT)
has the potential for applications in a range of
therapeutic contexts. However, successful SCNT
with human cells has proved challenging to achieve,
and thus far has only been reported with fetal or
infant somatic cells. In this study, we describe the
application of a recently developed methodology
for the generation of human ESCs via SCNT using
dermal fibroblasts from 35- and 75-year-old males.
Our study therefore demonstrates the applicability
of SCNT for adult human cells and supports further
investigation of SCNT as a strategy for regenerative
medicine.
SCNT is a potentially valuable tool for generating geneticallymatched stem cells for research and therapeutic purposes
(Lanza et al., 1999). Despite cloning success in numerous animal
species (Cibelli et al., 1998; Onishi et al., 2000; Polejaeva et al.,
2000;Wakayama et al., 1998, 2013;Wilmut et al., 1997), the deri-
vation of hESC lines from cloned human embryos has proven
elusive. Only one group has reported the creation of SCNT-
hESCs, and their lines were generated using fetal and infant fe-
male somatic cells as nuclear donors (Tachibana et al., 2013).
The incidence of many diseases that could be treated with
pluripotent cell derivatives increases with age, so applications
based on autologous cells would most likely involve aged nu-
clear donors. However, human SCNT has not yet been achieved
using aged donor nuclei. Here we show that using an approach
based on the protocol outlined by Tachibana et al. (2013), hESCs
can be generated by SCNT using dermal fibroblasts (DFBs) from
both amiddle-aged 35-year-oldmale and an elderly, 75-year-old
male, suggesting that age-associated changes are not neces-
sarily an impediment to SCNT-based nuclear reprogramming
of human cells.SCNT and induced pluripotent stem cell (iPSC) reprogram-
ming are both inefficient processes. The generation of patient-
specific pluripotent stem cells through either method depends
upon the completion of nuclear reprogramming, i.e., the
‘‘reversal of the differentiation state of a mature cell to one
that is characteristic of the undifferentiated embryonic state’’
(Hochedlinger and Jaenisch, 2006). This process likely includes
global changes in DNA methylation patterns and histone modifi-
cations, which must be reset to enable early embryonic gene
transcription (Blelloch et al., 2006). For many cell types, reprog-
ramming is more difficult for adult cells than for fetal/infant cells,
presumably at least in part because their epigenetic landscape
is further removed from the pluripotent state.
To examine the effect of nuclear donor age on SCNT, we
initially used a traditional SCNT protocol (see Figure S1 and
Supplemental Information available online) to reconstruct em-
bryos from 49MII stage oocytes obtained from three egg donors
and one DFB cell line (DFB-1) from a 35-year-old healthy adult
male. In these experiments, a total of three reconstructed
eggs developed to an early blastocyst stage at day 5, and one
of them developed further to a hatching blastocyst at day 6
(Table S1). Notably, all three blastocysts were derived from
oocytes obtained from one particular donor (DOE-B). After
removal of the zona pellucidae, the three blastocysts were plated
onto mitotically inactivated mouse fibroblast cells on day 6. The
two early stage blastocysts formed trophoblast-like colonies,
which died out a few days later. However, the hatched blastocyst
made an initial outgrowth resembling an ESC colony within
3 days and eventually resulted in a stable hESC line. This ESC
line (CHA-NT1) expressed OCT-4, SSEA-4, TRA-1-60, and
TRA-1-81 (FigureS1Ca) andcould form teratomas (FigureS1Cb).
However, cytogenetic testing and molecular genotyping re-
vealed it had a tetraploid karyotype (91, XXXY,-6, t[2:6]) (Fig-
ure S1Cc), indicating that we failed to fully enucleate the oocyte
prior to transfer of the donor cell nucleus.
Aneuploidy has been observed in monkey SCNT experiments
and may contribute to developmental arrest of cloned embryos
(Simerly et al., 2003). We therefore tested the karyotypes ofCell Stem Cell 14, 777–780, June 5, 2014 ª2014 Elsevier Inc. 777
Table 1. SCNT Human Embryo Development from Two Nuclear Donors
Treatment Nuclear Donorb Oocyte Donor
Embryo Development
Total Two-Cell Four-Cell Eight-Cell Morula Blastocysts Hatching Blastocysts ESC Line
30 min DFB-2 DOE-D 12 11 11 8 2 1 0 0
DOE-E 12 11 8 8 3 0 0 0
DFB-1 DOE-F 9 8 7 6 2 0 0 0
DOE-G 5 3 3 3 2 1 0 0
Subtotal 38 33 29 25 9 2 0 0
2 hr DFB-2 DOE-D 12 11 10 9 4 2 1 1a
DOE-E 12 11 9 9 3 0 0 0
DFB-1 DOE-F 10 8 8 6 2 0 0 0
DOE-G 5 4 4 4 3 1 1 1a
Subtotal 39 34 31 28 12 3 2 2a
DFB-1: 35-year-old male; DFB-2: 75-year-old male. Incubation time prior to activation (30 min versus 2 hr) does not drastically alter cloning efficiency;
however, the hatching blastocysts were obtained only from the 2 hr group. See also Table S1 and Table S2.
aKaryotyping showed normal 46 XY diploidy.
bThere were no significant differences between the two treatment groups at any developmental stage (X2-test, p > 0.05).
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as those of the two nonhatching blastocysts. Due to the limited
amount of material, we used a molecular karyotyping method
that involves whole-genome amplification from a single cell
(Chung et al., 2009; Treff et al., 2010). Interestingly, of the eight
samples that generated a quantifiable amount of DNA, all of
them had normal diploid karyotypes, and thus it did not seem
that aneuploidy was the main cause of developmental arrest in
these embryos (Table S2). We also tested supplementation of
half of the cloned embryos with mRNA for two centrosomal
proteins that might have been depleted during enucleation
(Simerly et al., 2003) (Figure S1Cd), but this approach did not
enhance cloning efficiency in our hands (Table S1).
As we were not able to generate diploid SCNT hESCs with our
original protocol, we then moved to a different approach. Tech-
nical changes to an otherwise standard SCNT protocol helped
Mitalipov and colleagues achieve generation of human SCNT-
hESCs (Tachibana et al., 2013) using young (infant/fetal) donor
cells. However the question remained of whether the same
method would be effective with adult donor nuclei of different
ages. In addition to differences in epigenetic signature relative
to fetal or embryonic cells (Blelloch et al., 2006), age-related
changes such as shortened telomeres and oxidative DNA
damage could hinder successful reprogramming of elderly
adult donor nuclei. SCNT studies in cattle have examined the
effects of somatic donor nucleus age on cloning efficiency
(Tian et al., 2003), but it remains unclear whether donor age
impedes SCNT cloning success. To examine this issue for
human SCNT, we used 77 MII stage oocytes collected from
four egg donors using the same ovarian stimulation regimen as
in the first set of experiments and two male donors, one aged
35 and one aged 75, as adult nuclear donors. Our procedures
and culture media were similar to those described by Tachibana
et al. (2013), but about half of the reconstructed eggs were
activated 2 hr instead of 30 min after fusion. By day 6, we ob-
tained five total blastocysts: two expanded from the 30 min
group and three expanded from the 2 hr group, but only those
from the 2 hr group developed to become hatching blastocysts.778 Cell Stem Cell 14, 777–780, June 5, 2014 ª2014 Elsevier Inc.As in the first set of experiments, all of the cloned embryos that
developed to blastocysts came from oocytes obtained from
particular egg donors (DOE-D and DOE-G) (Table 1). All five
blastocysts were plated onto MEFs in hESC-derivation medium,
but only the hatching blastocysts produced initial outgrowths
and led to the generation of two karyotypically normal (46, XY)
diploid ESC lines, one from the 75-year-old donor (CHA-NT2)
and one from the 35-year-old donor (CHA-NT4) (Figure 1).
Sixteen Short Tandem Repeat (STR) markers located at 15
human autosomal loci and 1 X/Y locus confirmed that the
genotypes of both CHA-NT2 and CHA-NT4 hESC lines perfectly
matched their respective nuclear donors but were different from
their oocyte donors (Figure 1C). We also verified that the mito-
chondrial genomes of CHA-NT2 and CHA-NT4 matched those
of oocyte donors (Figure 1D), confirming that the cytoplasm
of our SCNT-hESC lines originated from the donor oocytes.
CHA-NT2 and CHA-NT4 hESCs expressed OCT-4, SSEA-4,
TRA-1-60, and TRA-1-81 (Figure 1A) and showed a growth
rate similar to that of conventional IVF embryo-derived ESCs
(CHA-hES-15, p55) (Lee et al., 2010). We verified that the DFB
cells did not contain any OCT-4-, SSEA-4-, TRA-1-60-, or
TRA-1-81-positive cells (data not shown), supporting the finding
that CHA-NT2 and CHA-NT4 hESCs were the result of reprog-
ramming and not an artifact due to nuclear transfer from a
contaminating multipotent cell. We confirmed spontaneous
differentiation into all three germ layers in vitro by RT-PCR (Fig-
ure S2A) and immunostaining of embryoid bodies (Figure S2C).
Teratoma formation assays also demonstrated the outgrowth
of tissue from all three germ layers (Figure S2B), further confirm-
ing the pluripotency of the CHA-NT2 line. We also tested the
recovery of CHA-NT2 after a standard cryopreservation pro-
cedure and found that 60.6% (60/99) of colonies survived and
regrew on MEFs. In addition, a normal karyotype was confirmed
up to at least 30 passages (data not shown).
The slightly prolonged incubation time before activation that
we applied may provide extra time for reprogramming before
the start of embryonic gene transcription, which begins by the
eight-cell stage for humans (Telford et al., 1990; Zhang et al.,
Figure 1. Pluripotency, Cytogenetic, and Genetic Analysis of Human SCNT ESC Lines
(A) SCNT-derived hatching blastocysts and their ESC colonies. Both SCNT ESC lines expressed standard stem cell markers: OCT-4, SSEA-4, TRA-1-60, and
TRA-1-81. Bars indicate 100 m. (B) Cytogenetic G-banding analysis showed that CHA-NT2 and CHA-NT4 had normal male karyotypes (46, XY). (C) Nuclear DNA
genotyping using 16 STRmarkers (15 on autosomal loci and 1 on X/Y locus), and (D) Mitochondrial DNA genotyping on three single nucleotide polymorphic (SNP)
sites.m.8794C > T (rs2298007),m.10398A > G (rs2853826), andm.8697G > A (rs28358886) demonstrate that the nuclear DNAs in both CHA-NT2 and CHA-NT4
were exclusively derived from male DFB cells, and mt-DNA were derived from the oocytes. See also Figures S1 and S2.
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cloned embryos. Similar results have been observed in animal
studies (Aston et al., 2006; Liu et al., 2001; Wakayama et al.,
1998). We used both a 30 min and 2 hr incubation time with
the 35- and 75-year-old donor nuclei and found no differences
in terms of embryo development up to the blastocyst stage (p
> 0.05, X2-test), but we only obtained hatching blastocysts and
subsequent ESC lines from the 2 hr treatment group (Table 1).
As we saw in our earlier experiments, the embryos that devel-
oped the furthest were from the same oocyte donors even
though the SCNT procedure was different. This finding suggests
that genetic variation between egg donorsmay play an important
role in the developmental potential of cloned embryos and is
consistent with observations made by Tachibana et al. (2013).
Despite the success of SCNT in various animals, the genera-
tion of human ESC lines by SCNT has been notoriously difficult,
with only one report demonstrating its use until now. The exact
reason or reasons why the establishment of human ESC lines
with SCNT is more difficult than it is for other species remains
to be determined, although the results we report here suggest
that aneuploidy is not a major factor. In this study, we confirm
that modifications made to traditional SCNT procedures by
Tachibana et al. (2013) allow the generation of hESCs using
nuclear transfer, and we further show that refinement of this
protocol allows the generation of SCNT hESCs using adult do-
nors. Thus, despite epigenetic and other age-related changes
that could hinder reprogramming, middle-aged and elderly adult
donors can be used to generate pluripotent stem cells using
nuclear transplantation. Our findings with regard to the effect
of adjusting the postfusion interval also suggest that further
optimization of SCNT protocols may allow this approach to be
used more widely in regenerative medicine.SUPPLEMENTAL INFORMATION
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